Report Update Nov 1, 2024

Kazakhstan - Medicaments Containing Insulin But not Antibiotics in Measured Doses - Market Analysis, Forecast, Size, Trends and Insights

Single report

Sent by email within 24h (Mon-Fri)

$599 Basic Edition

$2095 Professional Edition

What's the difference?

Subscription

Online access and download

from $350/month

Get instant access to more than 2 million reports, dashboards, and datasets on the IndexBox Platform.

View Pricing

Kazakhstan: Market for Medicaments Containing Insulin But Not Antibiotics In Measured Doses 2024

Market Size for Medicaments Containing Insulin But Not Antibiotics In Measured Doses in Kazakhstan

The Kazakh prophylactic medicaments containing insulin market skyrocketed to $X in 2022, rising by 24% against the previous year. This figure reflects the total revenues of producers and importers (excluding logistics costs, retail marketing costs, and retailers' margins, which will be included in the final consumer price). In general, consumption saw a remarkable increase. Over the period under review, the market attained the peak level in 2022 and is expected to retain growth in the immediate term.

Exports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Exports from Kazakhstan

In 2022, overseas shipments of medicaments containing insulin but not antibiotics in measured doses decreased by -7.3% to X kg, falling for the second year in a row after two years of growth. Over the period under review, exports showed a significant contraction. The pace of growth appeared the most rapid in 2019 when exports increased by 8,700% against the previous year. The exports peaked at X tons in 2012; however, from 2013 to 2022, the exports failed to regain momentum.

In value terms, prophylactic medicaments containing insulin exports stood at $X in 2022. In general, exports recorded a dramatic contraction. The most prominent rate of growth was recorded in 2019 when exports increased by 225,935% against the previous year. The exports peaked at $X in 2012; however, from 2013 to 2022, the exports stood at a somewhat lower figure.

Exports by Country

Kyrgyzstan (X kg) was the main destination for prophylactic medicaments containing insulin exports from Kazakhstan, with a approx. 100% share of total exports.

From 2012 to 2022, the average annual rate of growth in terms of volume to Kyrgyzstan stood at -18.7%.

In value terms, Kyrgyzstan ($X) also remains the key foreign market for medicaments containing insulin but not antibiotics in measured doses exports from Kazakhstan.

From 2012 to 2022, the average annual rate of growth in terms of value to Kyrgyzstan amounted to -13.1%.

Export Prices by Country

The average prophylactic medicaments containing insulin export price stood at $X per ton in 2022, with an increase of 18% against the previous year. Over the period under review, the export price showed a temperate increase. The pace of growth appeared the most rapid in 2019 when the average export price increased by 2,469% against the previous year. Over the period under review, the average export prices reached the maximum in 2022 and is likely to continue growth in years to come.

As there is only one major export destination, the average price level is determined by prices for Kyrgyzstan.

From 2012 to 2022, the rate of growth in terms of prices for Kyrgyzstan amounted to +6.8% per year.

Imports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Imports into Kazakhstan

Prophylactic medicaments containing insulin imports into Kazakhstan soared to X tons in 2022, increasing by 23% compared with 2021 figures. Over the period under review, imports recorded strong growth. The growth pace was the most rapid in 2020 with an increase of 47%. Imports peaked in 2022 and are expected to retain growth in years to come.

In value terms, prophylactic medicaments containing insulin imports skyrocketed to $X in 2022. Overall, imports enjoyed a prominent increase. The pace of growth was the most pronounced in 2020 with an increase of 66% against the previous year. Over the period under review, imports hit record highs in 2022 and are likely to see gradual growth in the near future.

Imports by Country

Brazil (X tons), Germany (X tons) and France (X tons) were the main suppliers of prophylactic medicaments containing insulin imports to Kazakhstan, with a combined 92% share of total imports.

From 2012 to 2022, the biggest increases were recorded for Brazil (with a CAGR of +1,655.1%), while purchases for the other leaders experienced more modest paces of growth.

In value terms, Brazil ($X) constituted the largest supplier of medicaments containing insulin but not antibiotics in measured doses to Kazakhstan, comprising 51% of total imports. The second position in the ranking was taken by Germany ($X), with a 21% share of total imports. It was followed by Italy, with a 19% share.

From 2012 to 2022, the average annual growth rate of value from Brazil amounted to +2,204.1%. The remaining supplying countries recorded the following average annual rates of imports growth: Germany (+8.0% per year) and Italy (+18.5% per year).

Import Prices by Country

In 2022, the average prophylactic medicaments containing insulin import price amounted to $X per ton, stabilizing at the previous year. In general, the import price, however, continues to indicate a slight setback. The most prominent rate of growth was recorded in 2020 when the average import price increased by 13%. The import price peaked at $X per ton in 2014; however, from 2015 to 2022, import prices remained at a lower figure.

There were significant differences in the average prices amongst the major supplying countries. In 2022, amid the top importers, the country with the highest price was Italy ($X per ton), while the price for Germany ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Brazil (+31.3%), while the prices for the other major suppliers experienced mixed trend patterns.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :

What are the largest markets for medicaments containing insulin but not antibiotics in measured doses in the world?

The countries with the highest volumes of in 2021 were China, the United States and India, with a combined 52% share of global consumption.

What are the largest producers of medicaments containing insulin but not antibiotics in measured doses in the world?

The countries with the highest volumes of in 2021 were China, the United States and India, together accounting for 52% of global production.

What are the leading suppliers of medicaments containing insulin but not antibiotics in measured doses to Kazakhstan?

In value terms, the largest prophylactic medicaments containing insulin suppliers to Kazakhstan were Denmark, Italy and Germany, together accounting for 79% of total imports.

What are the leading importers of medicaments containing insulin but not antibiotics in measured doses from Kazakhstan?

In value terms, Kyrgyzstan remains the key foreign market for prophylactic medicaments containing insulin exports from Kazakhstan.

What is the average export price for medicaments containing insulin but not antibiotics in measured doses in Kazakhstan?

The average prophylactic medicaments containing insulin export price stood at $297,551 per ton in 2021, with an increase of 36% against the previous year.

What is the average import price for medicaments containing insulin but not antibiotics in measured doses in Kazakhstan?

The average prophylactic medicaments containing insulin import price stood at $200,974 per ton in 2021, reducing by -22.8% against the previous year.

This report provides an in-depth analysis of the market for prophylactic medicaments containing insulin in Kazakhstan. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.

Product coverage:

Prodcom 21201260 - Medicaments containing insulin but not antibiotics, for therapeutic or prophylactic uses, put up in measured doses or for retail sale

Country coverage:

Kazakhstan

Data coverage:

Market volume and value
Per Capita consumption
Forecast of the market dynamics in the medium term
Trade (exports and imports) in Kazakhstan
Export and import prices
Market trends, drivers and restraints
Key market players and their profiles

Reasons to buy this report:

Take advantage of the latest data
Find deeper insights into current market developments
Discover vital success factors affecting the market

This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.

In this report, you can find information that helps you to make informed decisions on the following issues:

How to diversify your business and benefit from new market opportunities
How to load your idle production capacity
How to boost your sales on overseas markets
How to increase your profit margins
How to make your supply chain more sustainable
How to reduce your production and supply chain costs
How to outsource production to other countries
How to prepare your business for global expansion

While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.

1. INTRODUCTION

Making Data-Driven Decisions to Grow Your Business
1. REPORT DESCRIPTION
2. RESEARCH METHODOLOGY AND AI PLATFORM
3. DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
4. GLOSSARY AND SPECIFIC TERMS
2. EXECUTIVE SUMMARY

A Quick Overview of Market Performance
1. KEY FINDINGS
2. MARKET TRENDS This Chapter is Available Only for the Professional Edition PRO
3. MARKET OVERVIEW

Understanding the Current State of The Market and Its Prospects
1. MARKET SIZE
2. MARKET STRUCTURE
3. TRADE BALANCE
4. PER CAPITA CONSUMPTION
5. MARKET FORECAST TO 2030
4. MOST PROMISING PRODUCT

Finding New Products to Diversify Your Business
This Chapter is Available Only for the Professional Edition PRO
1. TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
2. BEST-SELLING PRODUCTS
3. MOST CONSUMED PRODUCT
4. MOST TRADED PRODUCT
5. MOST PROFITABLE PRODUCT FOR EXPORT
5. MOST PROMISING SUPPLYING COUNTRIES

Choosing the Best Countries to Establish Your Sustainable Supply Chain
This Chapter is Available Only for the Professional Edition PRO
1. TOP COUNTRIES TO SOURCE YOUR PRODUCT
2. TOP PRODUCING COUNTRIES
3. TOP EXPORTING COUNTRIES
4. LOW-COST EXPORTING COUNTRIES
6. MOST PROMISING OVERSEAS MARKETS

Choosing the Best Countries to Boost Your Exports
This Chapter is Available Only for the Professional Edition PRO
1. TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
2. TOP CONSUMING MARKETS
3. UNSATURATED MARKETS
4. TOP IMPORTING MARKETS
5. MOST PROFITABLE MARKETS
7. PRODUCTION

The Latest Trends and Insights into The Industry
1. PRODUCTION VOLUME AND VALUE
8. IMPORTS
The Largest Import Supplying Countries
1. IMPORTS FROM 2012–2023
2. IMPORTS BY COUNTRY
3. IMPORT PRICES BY COUNTRY
9. EXPORTS
The Largest Destinations for Exports
1. EXPORTS FROM 2012–2023
2. EXPORTS BY COUNTRY
3. EXPORT PRICES BY COUNTRY
10. PROFILES OF MAJOR PRODUCERS

The Largest Producers on The Market and Their Profiles
This Chapter is Available Only for the Professional Edition PRO
LIST OF TABLES
1. Key Findings In 2023
2. Market Volume, In Physical Terms, 2012–2023
3. Market Value, 2012–2023
4. Per Capita Consumption In 2012-2023
5. Imports, In Physical Terms, By Country, 2012–2023
6. Imports, In Value Terms, By Country, 2012–2023
7. Import Prices, By Country Of Origin, 2012–2023
8. Exports, In Physical Terms, By Country, 2012–2023
9. Exports, In Value Terms, By Country, 2012–2023
10. Export Prices, By Country Of Destination, 2012–2023
LIST OF FIGURES
1. Market Volume, In Physical Terms, 2012–2023
2. Market Value, 2012–2023
3. Market Structure – Domestic Supply vs. Imports, In Physical Terms, 2012-2023
4. Market Structure – Domestic Supply vs. Imports, In Value Terms, 2012-2023
5. Trade Balance, In Physical Terms, 2012-2023
6. Trade Balance, In Value Terms, 2012-2023
7. Per Capita Consumption, 2012-2023
8. Market Volume Forecast to 2030
9. Market Value Forecast to 2030
10. Products: Market Size And Growth, By Type
11. Products: Average Per Capita Consumption, By Type
12. Products: Exports And Growth, By Type
13. Products: Export Prices And Growth, By Type
14. Production Volume And Growth
15. Exports And Growth
16. Export Prices And Growth
17. Market Size And Growth
18. Per Capita Consumption
19. Imports And Growth
20. Import Prices
21. Production, In Physical Terms, 2012–2023
22. Production, In Value Terms, 2012–2023
23. Imports, In Physical Terms, 2012–2023
24. Imports, In Value Terms, 2012–2023
25. Imports, In Physical Terms, By Country, 2023
26. Imports, In Physical Terms, By Country, 2012–2023
27. Imports, In Value Terms, By Country, 2012–2023
28. Import Prices, By Country Of Origin, 2012–2023
29. Exports, In Physical Terms, 2012–2023
30. Exports, In Value Terms, 2012–2023
31. Exports, In Physical Terms, By Country, 2023
32. Exports, In Physical Terms, By Country, 2012–2023
33. Exports, In Value Terms, By Country, 2012–2023
34. Export Prices, By Country Of Destination, 2012–2023